Hunting Hill Global Capital as of March 31, 2019
Portfolio Holdings for Hunting Hill Global Capital
Hunting Hill Global Capital holds 13 positions in its portfolio as reported in the March 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 25.4 | $138M | 1.5M | 94.34 | |
Red Hat | 23.7 | $129M | 705k | 182.70 | |
Altaba | 10.4 | $57M | 765k | 74.12 | |
Mellanox Technologies | 10.0 | $54M | 460k | 118.36 | |
iShares FTSE/Xinhua China 25 Index (FXI) | 9.9 | $54M | 1.2M | 44.27 | |
Eli Lilly & Co. (LLY) | 9.6 | $52M | 400k | 129.76 | |
Bristol Myers Squibb (BMY) | 4.0 | $22M | 450k | 47.71 | |
iShares MSCI Hong Kong Index Fund (EWH) | 3.5 | $19M | 718k | 26.21 | |
Takeda Pharmaceutical (TAK) | 1.2 | $6.8M | 334k | 20.37 | |
Fox Corporation (FOX) | 1.0 | $5.4M | 150k | 35.88 | |
Dbx Etf Tr dbxtr har cs 300 (ASHR) | 0.9 | $4.9M | 172k | 28.73 | |
BlackRock Corporate High Yield Fund VI (HYT) | 0.4 | $2.2M | 217k | 10.26 | |
Manulife Finl Corp (MFC) | 0.0 | $170k | 10k | 17.00 |